BSN Capital Partners’s Arch Capital ACGL Stock Holding History

BSN Capital Partners’s Portfolio ACGL Stock Details ACGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,059	Closed	-$100K	–	25
2025 Q3	$100K	Hold	1,059	–	–	0.01%	9
2025 Q2	$100K	Buy	+1,059	New	+$97.7K	0.01%	9

Other funds holding ACGL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BSN Capital Partners's ACGL Position: Q4 2025 in Review

BSN Capital Partners sold out of Arch Capital (ACGL) in Q4 2025, closing a stake of 1,059 shares — an estimated $100K sold.

BSN Capital Partners first reported a position in ACGL in Q2 2025 and held it in 2 quarters. The position peaked at $100K in Q3 2025. 921 funds tracked by Wall St. Rank hold ACGL as of Q4 2025.

BSN Capital Partners reported no remaining Arch Capital position as of Q4 2025 after selling out during the quarter.
BSN Capital Partners sold 1,059 Arch Capital shares in Q4 2025, an estimated $100K.
BSN Capital Partners first reported a position in Arch Capital in Q2 2025 and held it in 2 quarters.
BSN Capital Partners's Arch Capital position peaked at $100K in Q3 2025.
921 funds tracked by Wall St. Rank held Arch Capital as of Q4 2025.

Based on BSN Capital Partners's 13F filing for Q4 2025, filed 28 Jan 2026.